One Penn State Professor Unmasks the Role Genetics Play in Human Faces

By Boen Wang,
The Daily Collegian
| 08. 07. 2015
Untitled Document
The lab is like many others. Located at the end of a long hall on the top floor of Carpenter building, it is filled with microscopes and desktop computers, sinks and samples of human hair. At the far end is a revolving door, the kind used for photography darkrooms, which leads to a clean room for DNA extraction. Shelves of PCR machines line one side of the room, and on the other side are freezers, most of which are “full of saliva — human saliva,” said research assistant Brooke Mattern.
On the countertop are 3-D printers used to make plastic models of human faces. The faces are scattered throughout the lab — arranged side by side on a cabinet, hanging by the dozen on a wall — and adorn biological anthropology professor Mark Shriver’s office door.
Faces fascinate Shriver.
Last March, Shriver coauthored a paper titled “Modeling 3D Facial Shape from DNA.” Drawing on data from hundreds of 3-D scans of human faces, including the faces of Penn State students, the paper purported to uncover the genetic factors...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...